Empaglif Tablet 10 mg contains Empagliflozin 10 mg, an SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor indicated for the treatment of type 2 diabetes mellitus in adults. It helps improve blood sugar control by promoting the elimination of excess glucose through the urine. In addition to lowering blood glucose levels, Empagliflozin has proven cardiovascular and renal protective benefits, making it a valuable treatment option for patients with diabetes and associated heart or kidney conditions.

Empaglif Tablet 10 mg works independently of insulin, making it an effective option either alone or in combination with other antidiabetic medicines. It also helps reduce the risk of hospitalization for heart failure and slows the progression of chronic kidney disease (CKD) in eligible patients. Furthermore, it may contribute to modest weight loss and a reduction in blood pressure, supporting overall metabolic and cardiovascular health.

Empaglif Tablet should always be used alongside a healthy diet, regular physical activity, and lifestyle modifications as advised by a qualified healthcare professional.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Empagliflozin 10 mg

How Empaglif Tablet Works

Empagliflozin belongs to the SGLT2 inhibitor class of medicines. It works by blocking the sodium-glucose co-transporter 2 (SGLT2) proteins in the kidneys, which are responsible for reabsorbing glucose back into the bloodstream.

By inhibiting SGLT2, excess glucose is removed from the body through the urine, leading to lower blood sugar levels. This mechanism also helps reduce pressure on the heart and kidneys, providing additional cardiovascular and renal benefits in appropriate patients.

Indications

Empaglif Tablet 10 mg is indicated for:

• Type 2 diabetes mellitus as an adjunct to diet and exercise
• Improvement of glycemic control in adults with type 2 diabetes
• Reduction of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
• Management of heart failure in eligible patients
• Slowing the progression of chronic kidney disease (CKD) in appropriate patients

Note: Empaglif Tablet is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Benefits of Empaglif Tablet

• Effectively lowers blood glucose levels
• Helps reduce HbA1c in patients with type 2 diabetes
• Supports heart health and reduces cardiovascular risk
• Helps lower the risk of hospitalization due to heart failure
• Protects kidney function in eligible patients
• May assist with modest weight loss
• May contribute to lowering blood pressure
• Convenient once-daily oral dosing

Dosage and Administration

Take Empaglif Tablet exactly as prescribed by your healthcare provider.

• Swallow the tablet whole with a glass of water.
• It may be taken with or without food.
• Take one dose daily at the same time each day.
• Maintain adequate hydration during treatment.
• Continue following your recommended diet, exercise program, and blood glucose monitoring schedule.

Do not change the dose or discontinue the medicine without consulting your physician.

Possible Side Effects

Like all medicines, Empaglif Tablet may cause side effects, although not everyone experiences them.

Common side effects include:

• Increased urination
• Urinary tract infections
• Genital yeast infections
• Increased thirst
• Mild dehydration
• Dizziness

Less common but serious side effects include:

• Diabetic ketoacidosis
• Severe urinary tract infections
• Kidney function impairment
• Low blood pressure
• Serious allergic reactions

Seek immediate medical attention if you experience severe abdominal pain, vomiting, rapid breathing, confusion, or signs of a serious infection.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions

Before taking Empaglif Tablet, inform your healthcare provider if you:

• Have kidney disease or reduced kidney function
• Have liver disease
• Have low blood pressure or dehydration
• Have a history of recurrent urinary tract or genital infections
• Have a history of diabetic ketoacidosis
• Are pregnant, planning to become pregnant, or breastfeeding
• Are taking insulin, sulfonylureas, diuretics, or other medicines that may interact with Empagliflozin

Regular monitoring of blood glucose, kidney function, blood pressure, and overall health is recommended during treatment.

Storage

• Store below 30°C in a cool and dry place.
• Protect from moisture and direct sunlight.
• Keep the tablets in their original packaging.
• Keep out of the reach of children.
• Do not use after the expiry date printed on the package.